After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

about

Deaths in triathletes: immersion pulmonary oedema as a possible cause.The year in cardiology 2017: heart failure.Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.

P2860

Q37425719-B3823146-BFFC-4574-AD2B-74A882B75933 Q50193302-D07E6DEE-DEA8-477F-8A35-CBD3A1CB0E10 Q55431118-6178376C-79E5-4BA8-86D5-305FDC86A6DA

P2860

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

Item

http://www.wikidata.org/entity/Q38807777

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

@en

type

Item

label

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

@en

prefLabel

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

@en

P1476

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction

@en

P2093

Akshay S Desai

http://www.w3.org/2001/XMLSchema#string

P2860

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Trends in prevalence and outcome of heart failure with preserved ejection fraction

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

P304

3135-3140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHW114

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pardeep S. Jhund

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27075872

http://www.w3.org/2001/XMLSchema#string

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

about

P2860

P2860

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698